Literature DB >> 18952046

High efficiency of ROS production by glycerophosphate dehydrogenase in mammalian mitochondria.

Tomás Mrácek1, Alena Pecinová, Marek Vrbacký, Zdenek Drahota, Josef Houstek.   

Abstract

We investigated hydrogen peroxide production in mitochondria with low (liver, heart, brain) and high (brown adipose tissue, BAT) content of glycerophosphate dehydrogenase (mGPDH). ROS production at state 4 due to electron backflow from mGPDH was low, but after inhibition of electron transport with antimycin A high rates of mGPDH-dependent ROS production were observed in liver, heart and brain mitochondria. When this ROS production was related to activity of mGPDH, many-fold higher ROS production was found in contrast to succinate- (39-, 28-, 3-fold) or pyruvate plus malate-dependent ROS production (32-, 96-, 5-fold). This specific rate of mGPDH-dependent ROS production was also exceedingly higher (28-, 66-, 22-fold) compared to that in BAT. mGPDH-dependent ROS production was localized to the dehydrogenase+CoQ and complex III, the latter being the highest in all mitochondria but BAT. Our results demonstrate high efficiency of mGPDH-dependent ROS production in mammalian mitochondria with a low content of mGPDH and suggest its endogenous inhibition in BAT.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18952046     DOI: 10.1016/j.abb.2008.10.011

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  25 in total

1.  Moderate dependence of reactive oxygen species production on membrane potential in avian muscle mitochondria oxidizing glycerol 3-phosphate.

Authors:  Motoi Kikusato; Masaaki Toyomizu
Journal:  J Physiol Sci       Date:  2015-09-03       Impact factor: 2.781

2.  The metabolome profiling and pathway analysis in metabolic healthy and abnormal obesity.

Authors:  H-H Chen; Y J Tseng; S-Y Wang; Y-S Tsai; C-S Chang; T-C Kuo; W-J Yao; C-C Shieh; C-H Wu; P-H Kuo
Journal:  Int J Obes (Lond)       Date:  2015-04-24       Impact factor: 5.095

Review 3.  Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release.

Authors:  Dmitry B Zorov; Magdalena Juhaszova; Steven J Sollott
Journal:  Physiol Rev       Date:  2014-07       Impact factor: 37.312

4.  Oxidative Stress in Response to Saturated Fat Ingestion Is Linked to Insulin Resistance and Hyperandrogenism in Polycystic Ovary Syndrome.

Authors:  Frank González; Robert V Considine; Ola A Abdelhadi; Anthony J Acton
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

Review 5.  Regulation of endothelial function by mitochondrial reactive oxygen species.

Authors:  Michael E Widlansky; David D Gutterman
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

6.  Deficiency of Mitochondrial Glycerol 3-Phosphate Dehydrogenase Contributes to Hepatic Steatosis.

Authors:  Yi Zheng; Hua Qu; Xin Xiong; Yuren Wang; Xiufei Liu; Linlin Zhang; Xiaoyu Liao; Qian Liao; Zheng Sun; Qin Ouyang; Gangyi Yang; Zhiming Zhu; Jing Xu; Hongting Zheng
Journal:  Hepatology       Date:  2019-03-15       Impact factor: 17.425

7.  Critical role of mitochondrial ROS is dependent on their site of production on the electron transport chain in ischemic heart.

Authors:  Ngonidzashe B Madungwe; Netanel F Zilberstein; Yansheng Feng; Jean C Bopassa
Journal:  Am J Cardiovasc Dis       Date:  2016-09-15

Review 8.  Mitochondria and reactive oxygen species.

Authors:  Francesco Addabbo; Monica Montagnani; Michael S Goligorsky
Journal:  Hypertension       Date:  2009-04-27       Impact factor: 10.190

9.  A refined analysis of superoxide production by mitochondrial sn-glycerol 3-phosphate dehydrogenase.

Authors:  Adam L Orr; Casey L Quinlan; Irina V Perevoshchikova; Martin D Brand
Journal:  J Biol Chem       Date:  2012-11-02       Impact factor: 5.157

Review 10.  A Simple Hydraulic Analog Model of Oxidative Phosphorylation.

Authors:  Wayne T Willis; Matthew R Jackman; Jeffrey I Messer; Sarah Kuzmiak-Glancy; Brian Glancy
Journal:  Med Sci Sports Exerc       Date:  2016-06       Impact factor: 5.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.